In addition, CB exhibits broader-spectrum activity in purified pDCs and in a lupus mouse model, significantly reducing levels of pro-inflammatory cytokines IL-1β, IL-17, TNF-α and the interferon-regulated gene TRAIL, both in vitro and in vivo. Here, IL17A is linked to systemic lupus erythematosus.